NewGenIvf Group Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	0.76	0.46	0.05
Cash & Short-Term Investments	0.76	0.46	0.05
Cash Growth	65.73%	746.04%	-
Accounts Receivable	0.17	0.05	0.01
Inventory	0.34	0.08	0.13
Other Current Assets	6.12	2.58	2.27
Total Current Assets	7.38	3.17	2.46
Net Property, Plant & Equipment	2.29	0.37	0.45
Other Intangible Assets	21.42	-	-
Other Long-Term Assets	1.63	0.03	1.58
Total Assets	32.72	3.58	4.49
Accounts Payable	0.78	1.3	0.17
Accrued Expenses	0.71	0.5	0.24
Current Portion of Long-Term Debt	0.26	0.58	-
Current Portion of Leases	0.24	0.11	0.21
Unearned Revenue	0.11	0.06	0.01
Other Current Liabilities	0.27	0.17	0.49
Total Current Liabilities	2.37	2.72	1.12
Long-Term Debt	4.1	2.33	-
Long-Term Leases	0.27	0.01	0.12
Total Long-Term Liabilities	4.37	2.34	0.12
Total Liabilities	6.74	5.06	1.24
Additional Paid-in Capital	17.88	-0.08	4.2
Accumulated Other Comprehensive Income	-0.14	0.02	-0.01
Retained Earnings	8.89	-0.99	-0.46
Total Common Shareholders' Equity	26.63	-1.05	3.74
Minority Interest	-0.64	-0.43	-0.49
Shareholders' Equity	25.99	-1.48	3.25
Total Liabilities & Equity	32.72	3.58	4.49
Total Debt	4.86	3.03	0.33
Net Cash (Debt)	-4.11	-2.57	-0.28
Net Cash Per Share	-1.26	-21616.64	-2901.10
Book Value	26.63	-1.05	3.74
Book Value Per Share	8.19	-8811.88	38920.60
Tangible Book Value	5.22	-1.05	3.74
Tangible Book Value Per Share	1.61	-8811.88	38920.60

SEC Filings: 10-K · 10-Q